| |
| |
|
| Insider
Information: |
Toth Robert Joseph Jr |
| Relationship: |
Director |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,566 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$132 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,566 |
|
|
| Total
Value |
$132 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kintara Therapeutics, Inc |
KTRA |
Director |
2021-04-29 |
1,566 |
2014-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
325 |
1,566 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3 |
1,241 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,238 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,230 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,222 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2020-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,206 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,198 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,190 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2019-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,182 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2019-03-29 |
4 |
A |
$0.49 |
$36 |
D/D |
74 |
11,739 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.34 |
$25 |
D/D |
74 |
11,665 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2018-09-28 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,591 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2018-06-29 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,517 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2018-03-30 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,443 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-12-31 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,369 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-09-29 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,295 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,221 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,147 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
11,073 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$237 |
D/D |
74 |
10,999 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$160 |
D/D |
50 |
10,925 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-03-18 |
4 |
B |
$1.30 |
$32,500 |
D/D |
25,000 |
43,500 |
2.39 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-02-05 |
4 |
B |
$0.88 |
$7,920 |
D/D |
9,000 |
18,500 |
2.39 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-01-31 |
4 |
B |
$0.87 |
$1,740 |
D/D |
2,000 |
9,500 |
2.31 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-01-29 |
4 |
B |
$0.91 |
$6,825 |
D/D |
7,500 |
7,500 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
